{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:05:32Z","timestamp":1785416732837,"version":"3.56.0"},"reference-count":34,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the pharmacological and psychosocial complexities in LGBTQIA+ cancer care and to highlight the role of pharmacists in delivering inclusive, culturally competent care to optimise treatment outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>A comprehensive literature search was conducted using PubMed, Scopus, Web of Science, and Google Scholar databases. Search terms included combinations of \u201cLGBTQIA+\u201d, \u201ctransgender\u201d, \u201csexual and gender minorities\u201d, \u201ccancer\u201d, \u201concology\u201d, \u201cgender-affirming hormone therapy\u201d, \u201cantiretroviral therapy\u201d, \u201cdrug interactions\u201d, \u201cpharmacokinetics\u201d, \u201cpharmacodynamics\u201d, \u201cculturally competent care\u201d, \u201cminority stress\u201d, \u201cpharmacist\u201d, and \u201cpractitioner positioning\u201d. Peer-reviewed articles, systematic reviews, clinical reports, and position statements published in English were included. Reference lists were hand-searched, and relevant grey literature and clinical guidelines were consulted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data summary<\/jats:title>\n                    <jats:p>LGBTQIA+ cancer patients often require concurrent therapies, including gender-affirming hormone therapy (GAHT), antiretroviral therapy (ART), and oncology treatments, which create risks of drug interactions, cumulative toxicities, and altered pharmacokinetics and pharmacodynamics. Comorbidities and polypharmacy may further complicate management. These challenges are compounded by minority stress, healthcare disparities, and gaps in provider knowledge. Evidence shows that healthcare professional positioning influences patient disclosure, treatment engagement, and outcomes. Inclusive approaches facilitate accurate medication histories and safer care, while egalitarian or non-inclusive practices may lead to missed interactions and unmet needs, particularly for transgender patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Pharmacists must adopt inclusive, culturally competent practices alongside pharmacological expertise to optimise medication safety, improve adherence, and reduce disparities in LGBTQIA+ oncology care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552261470050","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:32:47Z","timestamp":1785245567000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond neutrality in LGBTQIA+ cancer care: Optimising outcomes through inclusive and culturally competent pharmacy practice"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9174-7120","authenticated-orcid":false,"given":"Sunil","family":"Shrestha","sequence":"first","affiliation":[{"name":"Kathmandu Cancer Center"},{"name":"Nepal Health Research and Innovation Foundation, Lalitpur, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1952-642X","authenticated-orcid":false,"given":"Nabin","family":"Pathak","sequence":"additional","affiliation":[{"name":"Madan Bhandari Academy of Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4284-0134","authenticated-orcid":false,"given":"Ajaya","family":"Acharya","sequence":"additional","affiliation":[{"name":"Kathmandu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-4318","authenticated-orcid":false,"given":"Simit","family":"Sapkota","sequence":"additional","affiliation":[{"name":"Kathmandu Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Nissen","sequence":"additional","affiliation":[{"name":"The University of Queensland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhu","family":"Paudyal","sequence":"additional","affiliation":[{"name":"King's College London"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dialog.2025.100229"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.0441"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21288"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/pon.4674"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.918016"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.873642"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.832657"},{"issue":"4","key":"e_1_3_2_9_2","article-title":"Drug-Drug interactions in transgender patients receiving antiretroviral and hormonal therapy: a systematic review of clinical studies and reports","volume":"17","author":"Yadav R","year":"2025","unstructured":"Yadav R, Krishna E, Shrivastava B, et al. Drug-Drug interactions in transgender patients receiving antiretroviral and hormonal therapy: a systematic review of clinical studies and reports. Cureus 2025; 17(4): e81918.","journal-title":"Cureus"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-023-04373-3"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2021.12.008"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2015.02.003"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70315-8"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-023-02530-9"},{"issue":"4","key":"e_1_3_2_15_2","article-title":"Health care disparities among lesbian, gay, bisexual, and transgender youth: a literature review","volume":"9","author":"Hafeez H","year":"2017","unstructured":"Hafeez H, Zeshan M, Tahir MA, et al. Health care disparities among lesbian, gay, bisexual, and transgender youth: a literature review. Cureus 2017; 9(4): e1184.","journal-title":"Cureus"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182211801"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.5688\/ajpe7835"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/164_2023_665"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200948030-00001"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03555.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-014-2399-7"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.16097"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.05.008"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/1076029620954282"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Rostami B Nematbakhsh M Pezeshki Z et al. Effect of testosterone on cisplatin-induced nephrotoxicity in surgically castrated rats. Research Article 6 Nephro-Urology Monthly.","DOI":"10.5812\/numonthly.21546"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q422"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43044-023-00385-y"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-017-3392-8"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.2337\/cd21-0011"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/87551225211073942"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1089\/trgh.2018.0038"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/10781552231205025"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy8030130"},{"key":"e_1_3_2_34_2","article-title":"Encouraging LGBTQIA+ inclusive cancer care in hospital settings: a critically integral part for equitable oncology","volume":"11","author":"Pathak N","year":"2025","unstructured":"Pathak N, Kanak MP, Dhakal M, et al. Encouraging LGBTQIA+ inclusive cancer care in hospital settings: a critically integral part for equitable oncology. JCO Glob Oncol 2025; 11: e2500403.","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riad077"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261470050","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552261470050","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261470050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:48:05Z","timestamp":1785415685000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552261470050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":34,"alternative-id":["10.1177\/10781552261470050"],"URL":"https:\/\/doi.org\/10.1177\/10781552261470050","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"article-number":"10781552261470050"}}